Morgan Stanley
VIVS

Morgan Stanley’s VivoSim Labs VIVS Stock Holding History

Morgan Stanley’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$72 Sell
50
-18
-26% -$35 ﹤0.01% 7872
2025
Q4 		$123 Hold
68
– – ﹤0.01% 7686
2025
Q3 		$199 Sell
68
-4
-6% -$9 ﹤0.01% 7601
2025
Q2 		$106 Sell
72
-4,918
-99% -$9.02K ﹤0.01% 7643
2025
Q1 		$11.2K Buy
4,990
+3,328
+200% +$16.3K ﹤0.01% 6768
2024
Q4 		$9.17K Sell
1,662
-44
-3% -$223 ﹤0.01% 6831
2024
Q3 		$10.4K Sell
1,706
-1,788
-51% -$12.4K ﹤0.01% 6709
2024
Q2 		$31.9K Sell
3,494
-18
-0.5% -$212 ﹤0.01% 6312
2024
Q1 		$43.4K Sell
3,512
-3,596
-51% -$44.8K ﹤0.01% 6269
2023
Q4 		$94.7K Buy
7,108
+3,865
+119% +$57.4K ﹤0.01% 6179
2023
Q3 		$48.6K Sell
3,243
-1,355
-29% -$23.9K ﹤0.01% 6178
2023
Q2 		$93.2K Sell
4,598
-61
-1% -$1.38K ﹤0.01% 5984
2023
Q1 		$122K Buy
4,659
+1,853
+66% +$44.3K ﹤0.01% 5934
2022
Q4 		$47.5K Sell
2,806
-14
-0.5% -$280 ﹤0.01% 6312
2022
Q3 		$70K Buy
2,820
+1,096
+64% +$35K ﹤0.01% 6249
2022
Q2 		$36K Buy
1,724
+427
+33% +$13.3K ﹤0.01% 6761
2022
Q1 		$58K Sell
1,297
-436
-25% -$18.1K ﹤0.01% 6635
2021
Q4 		$75K Sell
1,733
-633
-27% -$40.7K ﹤0.01% 6607
2021
Q3 		$193K Sell
2,366
-275
-10% -$25.1K ﹤0.01% 6021
2021
Q2 		$298K Buy
2,641
+373
+16% +$37.5K ﹤0.01% 5812
2021
Q1 		$262K Buy
2,268
+998
+79% +$156K ﹤0.01% 5500
2020
Q4 		$187K Buy
1,270
+570
+81% +$64.9K ﹤0.01% 5626
2020
Q3 		$67K Buy
700
+482
+221% +$62.1K ﹤0.01% 5603
2020
Q2 		$29K Sell
218
-68
-24% -$8.29K ﹤0.01% 5891
2020
Q1 		$28K Sell
286
-35
-11% -$2.83K ﹤0.01% 5697
2019
Q4 		$27K Sell
321
-8
-2% -$749 ﹤0.01% 6032
2019
Q3 		$21K Sell
329
-59
-15% -$4.97K ﹤0.01% 5999
2019
Q2 		$48K Sell
388
-394
-50% -$74.5K ﹤0.01% 5626
2019
Q1 		$186K Sell
782
-519
-40% -$131K ﹤0.01% 5103
2018
Q4 		$299K Buy
1,301
+3
+0.2% +$756 ﹤0.01% 5101
2018
Q3 		$358K Sell
1,298
-171
-12% -$51.4K ﹤0.01% 5176
2018
Q2 		$493K Buy
1,469
+245
+20% +$80.7K ﹤0.01% 5111
2018
Q1 		$302K Buy
1,224
+121
+11% +$35.3K ﹤0.01% 5279
2017
Q4 		$355K Sell
1,103
-448
-29% -$167K ﹤0.01% 5162
2017
Q3 		$826K Buy
1,551
+153
+11% +$81.4K ﹤0.01% 4559
2017
Q2 		$882K Sell
1,398
-692
-33% -$465K ﹤0.01% 4462
2017
Q1 		$1.59M Sell
2,090
-212
-9% -$168K ﹤0.01% 4017
2016
Q4 		$1.87M Buy
2,302
+1,241
+117% +$985K ﹤0.01% 3987
2016
Q3 		$965K Sell
1,061
-173
-14% -$169K ﹤0.01% 4070
2016
Q2 		$1.1M Sell
1,234
-359
-23% -$241K ﹤0.01% 3901
2016
Q1 		$830K Sell
1,593
-430
-21% -$219K ﹤0.01% 4095
2015
Q4 		$1.21M Sell
2,023
-123
-6% -$89.2K ﹤0.01% 3918
2015
Q3 		$1.38M Sell
2,146
-668
-24% -$507K ﹤0.01% 3833
2015
Q2 		$2.55M Buy
2,814
+754
+37% +$844K ﹤0.01% 3401
2015
Q1 		$1.75M Sell
2,060
-377
-15% -$521K ﹤0.01% 3702
2014
Q4 		$4.24M Buy
2,437
+233
+11% +$358K ﹤0.01% 2884
2014
Q3 		$3.37M Sell
2,204
-217
-9% -$393K ﹤0.01% 2999
2014
Q2 		$4.85M Sell
2,421
-772
-24% -$1.29M ﹤0.01% 2692
2014
Q1 		$5.86M Sell
3,193
-1,339
-30% -$3.11M ﹤0.01% 2436
2013
Q4 		$12M Buy
4,532
+3,317
+273% +$6.51M 0.01% 1788
2013
Q3 		$1.68M Buy
+1,215
New +$1.7M ﹤0.01% 3378

Other funds holding VIVS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

Morgan Stanley's VIVS Position: Q1 2026 in Review

Morgan Stanley reduced its VivoSim Labs (VIVS) stake by 26% in Q1 2026, selling an estimated $35 and leaving 50 shares worth $72. The position accounts for ﹤0.01% of the portfolio, ranked #7872.

Morgan Stanley first reported a position in VIVS in Q3 2013 and has held it in 51 quarters since. The position peaked at $12M in Q4 2013. 24 funds tracked by Wall St. Rank hold VIVS as of Q1 2026.

  • Morgan Stanley held 50 shares of VivoSim Labs worth $72 as of Q1 2026.
  • Morgan Stanley sold 18 VivoSim Labs shares in Q1 2026, an estimated $35.
  • VivoSim Labs made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7872 holding.
  • Morgan Stanley first reported a position in VivoSim Labs in Q3 2013 and has held it in 51 quarters since.
  • Morgan Stanley's VivoSim Labs position peaked at $12M in Q4 2013.
  • 24 funds tracked by Wall St. Rank held VivoSim Labs as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.